Lee-Anne Stayner

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

Albiruni R. Abdul Razak, Morten Mau‐Sørensen, Nashat Gabrail et al. · Journal of Clinical Oncology · 2016 · 247 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Anastasios Stathis, Sebastién J. Hotte, Eric X. Chen et al. · Clinical Cancer Research · 2011 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)

Anna Spreafico, Alya Heirali, Daniel Vilarim Araújo et al. · Annals of Oncology · 2023 · 98 citations · Full text

Life Sciences, Microbiology, Oncology +17

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

Juneko E. Grilley‐Olson, Philippe L. Bédard, Angelica Fasolo et al. · Investigational New Drugs · 2016 · 80 citations · Full text

Medicine, Oncology, Pharmacology +15

Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials

Yada Kanjanapan, Daphne Day, Marcus O. Butler et al. · European Journal of Cancer · 2018 · 71 citations

Pharmacy, Immunology, Clinical Immunology +14